Last updated on September 2017

Phase II/III Randomized study of Sorafenib plus Doxorubicin versus sorafenib in patients with advanced HCC

Other Details:

For more information, please contact:
646.776.7532 (local)

For Study Locations, Click Here

Find a site near you

Start Over

Research Center

Located in: Additional Locations, XX Puerto Rico
  Connect »